Literature DB >> 14392841

[Animal experimental nephritis and dextran-allergy].

J MOELLER.   

Abstract

Entities:  

Keywords:  DEXTRAN; GLOMERULONEPHRITIS/experimental

Mesh:

Substances:

Year:  1955        PMID: 14392841     DOI: 10.1007/bf01467987

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  13 in total

1.  [Auto-antibodies in the renal pathology].

Authors:  H SARRE; K ROTHER
Journal:  Klin Wochenschr       Date:  1954-05-01

2.  Reactions to dextran.

Authors:  A W WILKINSON; I D STOREY
Journal:  Lancet       Date:  1953-11-07       Impact factor: 79.321

3.  Dextran and Pneumococcus polysaccharide cross-reactivity in skin tests and serum precipitin tests.

Authors:  G C BRYAN; J SCUDDER
Journal:  Ann N Y Acad Sci       Date:  1952-09       Impact factor: 5.691

4.  Production of precipitins and cutaneous sensitivity in man by injection of small amounts of dextran.

Authors:  E A KABAT; D BERG
Journal:  Ann N Y Acad Sci       Date:  1952-09       Impact factor: 5.691

5.  [Humoral factors in the pathogenesis of the human hypertension].

Authors:  J MOELLER
Journal:  Arch Kreislaufforsch       Date:  1952-09

6.  [Eosinophil count and eosinophils tests].

Authors:  R GROSS
Journal:  Medizinische       Date:  1953-03-21

7.  Investigations on dextran and its application as a plasma substitute.

Authors:  B INGELMAN
Journal:  Upsala Lakareforen Forh       Date:  1949-03-15

8.  Diffuse glomerulonephritis produced in rabbits by massive injections of bovine serum gamma globulin.

Authors:  R H MORE; D WAUGH
Journal:  J Exp Med       Date:  1949-05       Impact factor: 14.307

9.  Cardiac lesions produced in rabbits by massive injections of bovine serum gamma globulin.

Authors:  R H MORE; D WAUGH; S D KOBERNICK
Journal:  J Exp Med       Date:  1949-05       Impact factor: 14.307

10.  HISTOLOGICAL AND SEROLOGICAL SEQUENCES IN EXPERIMENTAL HYPERSENSITIVITY.

Authors:  C V Hawn; C A Janeway
Journal:  J Exp Med       Date:  1947-05-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.